Literature DB >> 23174173

Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.

Marzia Lotrionte, Giovanni Palazzoni, Antonio Abbate, Eugenia De Marco, Eleonora Mezzaroma, Silvia Di Persio, Giacomo Frati, Francesco Loperfido, Giuseppe Biondi-Zoccai.   

Abstract

Entities:  

Keywords:  Anthracycline; Cardiotoxicity; Echocardiography; Randomized clinical trial; Tissue Doppler imaging

Mesh：

Substances：

Year:  2012        PMID： 23174173     DOI： 10.1016/j.ijcard.2012.10.079

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

1.  Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy.

Authors:  Joy Marie Fulbright; Daniela E Egas-Bejar; Winston W Huh; Joya Chandra
Journal:  Cancer Chemother Pharmacol       Date:  2015-10-29       Impact factor: 3.333

Review 2.  Cardiovascular effects of Hodgkin's lymphoma: a review of literature.

Authors:  Aasems Jacob; Bragadheeswar Thyagarajan; Monisha Priyadarshini Kumar; Nasreen Shaikh; David Sharon
Journal:  J Cancer Res Clin Oncol       Date:  2017-12-18       Impact factor: 4.553

Review 3.  The breast cancer patient in the cardioncology unit.

Authors:  Daniela Cardinale; Vincenzo Caruso; Carlo M Cipolla
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

4.  Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients.

Authors:  Patrizia Vici; Laura Pizzuti; Teresa Gamucci; Domenico Sergi; Francesca Conti; Germano Zampa; Pietro Del Medico; Roy De Vita; Marcello Pozzi; Claudio Botti; Simona Di Filippo; Federica Tomao; Isabella Sperduti; Luigi Di Lauro
Journal:  J Cancer       Date:  2014-04-25       Impact factor: 4.207

5.  Cardiotoxicity due to chemotherapy for breast cancer: the dark side of the moon.

Authors:  Mariangela Peruzzi; Giovanni Palazzoni; Giuseppe Biondi-Zoccai; Marzia Lotrionte
Journal:  Anatol J Cardiol       Date:  2014-12-25       Impact factor: 1.596

6.  Preventing effect of astragalus polysaccharide on cardiotoxicity induced by chemotherapy of epirubicin: A pilot study.

Authors:  Xiaofang Li; Xin Guo; Jun Li; Li Yuan; Haixiong Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.